Evidence map›Paper›PMID 32669983›Full record

ArticleDose-response : a publication of International Hormesis Society

Susceptibility Assessment of Multidrug Resistant Bacteria to Natural Products.

Essam Hassan Mohamed, Youssef Saeed Alghamdi, Salama Mostafa Abdel-Hafez, Mohamed Mohamed Soliman, Saad H Alotaibi, Magdy Yassin Hassan, Nasr Al-Deen Hany, Hamada H Amer

Open access · goldAbstract read
In one paragraph

Article in Dose-response : a publication of International Hormesis Society. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Frontiers in microbiology · 2025
    Review
  4. Synthesis and Antiviral and Antitumor Activities of Novel 18International journal of molecular sciences · 2023
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Essam Hassan MohamedDepartment of Biology, Turabah University College, Taif University, Saudi Arabia.
Youssef Saeed AlghamdiDepartment of Biology, Turabah University College, Taif University, Saudi Arabia.
Salama Mostafa Abdel-HafezDepartment of Biology, Turabah University College, Taif University, Saudi Arabia.
Mohamed Mohamed SolimanClinical Laboratories Sciences, Turabah University College, Taif University, Turabah, Saudi Arabia.ORCID https://orcid.org/0000-0001-7208-7123
Saad H AlotaibiChemistry Department, Turabah University College, Turabah, Taif University, Saudi Arabia.
Magdy Yassin HassanDepartment of Biology, Turabah University College, Taif University, Saudi Arabia.
Nasr Al-Deen HanyMicrobiology Laboratory, King Faisal Medical Complex, Saudi Arabia.
Hamada H AmerChemistry Department, Turabah University College, Turabah, Taif University, Saudi Arabia.
Taif University · SAKing Faisal Specialist Hospital & Research Centre · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe aim of this study was to examine the effect of some natural compounds against multidrug-resistant bacteria.

methodsForty-three bacterial strains were collected. Disc diffusion and minimum inhibitory concentration (MIC) tests were carried out for natural compounds including quercetin,

results

conclusionsCurrent findings confirmed the beneficial effect of using natural products such as

Indexed as

acaciacloveDNA fragmentationmultiresistant bacteriaquercetinscanning electron microscope

Identifiers

PMID32669983
PMCPMC7338649
OpenAlexW3040073866

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.